Company Vision

Home  >>  About us  >>  Company Vision

Hotgen Biotech – Advanced Diagnostics Attributed to our Efforts.

Hotgen delivers reliable and actionable information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally.


As the slogan Advanced Diagnostics Attributed to our Efforts implies, Hotgen aims to become one of the global IVD leaders with continuous efforts to make diagnostics advanced and accurate. 

Advancing Diagnostics through Innovation 


We believe that fundamental changes to the way healthcare is practiced are inevitable, and we aim to successfully drive those changes well into the future. We deploy unique technologies that innovate transformative diagnostic products with clinical proven and economic outcomes.


Just name a few examples of our innovation as including:

  • UPTquikTM – the only POCT system in the world that combines Up-converting Phosphor Technology (UPT) and immunochromatography to quantitatively measure the concentration of target analytes in blood, serum, plasma and other specimens. 
  • Using the unique and chemically stable lanthanide-doped inorganic phosphors as reporters that up-converts the infrared excitation source to visible and readily detectable light, UPT is the next generation of clinical diagnostic technology that features high sensitivity, rapidity, simplicity and accuracy.
  • Golgi protein 73 (GP73) is a newly discovered biomarker that is more sensitive and specific than the traditional AFP to aid in the diagnosis of hepatocellular carcinoma. Hotgen is the first and only company that provides the commercially available quantitative measuring kit both in UPT and ELISA testing principle.
  • Fetal Fronectin (fFN) is a newly found trustworthy biomarker of increasing risk of premature delivery. The UPTtest fFN kit is the only available quantitative measuring kit for fFN.


The integration of these and existing technologies will drive greater quality, accessibility and effectiveness in healthcare.


Copyright:Hotgen Biotech Co., Ltd.